In a groundbreaking episode of “The Joy of Why” podcast, mathematician and statistician Emmanuel Candès discusses the impact of artificial intelligence (AI) on prediction science. Candès explains how AI models, often referred to as “black boxes,” can make successful predictions without fully understanding the underlying mechanisms. He also highlights the importance of quantifying uncertainty in…
Nanotechnology is transforming the healthcare industry with its potential to revolutionize drug delivery, diagnostics, and treatment of various diseases. Eight companies, including Sona Nanotech, Nanobiotix, and ARIZ Precision Medicine, are at the forefront of this revolution, developing innovative nanotechnology-based solutions for cancer treatment, autoimmune diseases, and other conditions. These companies are leveraging nanotechnology to create…
The biopharma industry is in need of talented minds to take promising pipelines to the clinic and beyond. Venture capitalists have nominated prominent founders and entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. These entrepreneurs have proven their expertise in hitting milestones, be it in the lab or…
Researchers have made a significant discovery in the study of chronic wasting disease (CWD), a fatal neurological illness affecting deer. The first detailed structure of an infectious prion responsible for CWD reveals a unique 180-degree twist, which could aid in vaccine development or explain why the disease hasn’t yet jumped to humans. This finding may…
Physicists at TU Wien in Austria have proposed a new explanation for the long-standing neutron lifetime problem. The team suggests that the discrepancy in measurements could be caused by free neutrons being in a mix of different states, with some in the ground state and others in higher-energy excited states. This would alter the neutrons’…
The biotech industry has seen a surge in the number of unicorns, with over 1,200 companies worldwide achieving valuations of over $1 billion. However, biotech unicorns are relatively rare, with only a few companies making it to the top. This article takes a closer look at 12 biotech unicorns that are making waves in the…
A recent article highlights the issue of missing data in scientific research, which can lead to biased results and undermine the validity of studies. Statisticians have developed techniques to deal with missing data, but the problem persists. The article explores the history of missing data and the efforts of statistician Donald Rubin to develop a…
Researchers at Curtin University have made a groundbreaking discovery in the field of nanotechnology. They found that molecules known as ligands attach more densely to flatter, platelet-shaped semiconductor nanocrystals than to spherical ones. This counterintuitive result could lead to significant improvements in LED and solar cell technology, as well as applications in biomedicine. Forecast for…
A recent surge in therapeutic progress has brought new hope to patients suffering from Duchenne muscular dystrophy, a severe form of inherited muscular dystrophy. Several biotech companies, including Wave Life Sciences, Sarepta Therapeutics, Capricor Therapeutics, Edgewise Therapeutics, Italfarmaco, and Avidity Biosciences, are making significant strides in developing innovative treatments, including RNA medicines, gene therapies, and…
Chemists have successfully synthesized anti-Bredt olefins (ABOs), a class of molecules previously thought too unstable to exist. This breakthrough offers a new path to synthesizing challenging drug candidates and could lead to innovative synthesis pathways for other complex molecules. Forecast for 6 months: Expect increased research and development in the field of organic chemistry, with…
